Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_2
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (50.0%)
N/A2 (50.0%)

Trials by Status

completed125%
unknown250%
active_not_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

Safety and Tolerance of a Novel Three-Strain Probiotic in Healthy Adults

NCT07566884
completednot_applicable

The Efficacy of White Kidney Bean on Oral Glucose Tolerance Test

NCT05756712
unknownphase_2

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

NCT04815967
unknownphase_2

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity

NCT04099667

Clinical Trials (4)

Showing 4 of 4 trials
NCT07566884Not Applicable

Safety and Tolerance of a Novel Three-Strain Probiotic in Healthy Adults

Active Not Recruiting
NCT05756712Not Applicable

The Efficacy of White Kidney Bean on Oral Glucose Tolerance Test

Completed
NCT04815967Phase 2

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

Unknown
NCT04099667Phase 2

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4